echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New anti-cancer compounds are introduced

    New anti-cancer compounds are introduced

    • Last Update: 2022-11-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    A team of researchers at the University of Kentucky's Markey Cancer Center has developed a new compound that promises to be a potential anti-cancer therapy
    to treat aggressive tumors.

    The study, led by Samuel G.
    Awuah Ph.
    D.
    , was published in Chemical Communications, with Adedamola Arojojoye, a graduate student in Awuah's lab, as the first author
    .

    The new gold-derived compound, created by Awuah's lab, is toxic to cancer cells but well tolerated in mice, giving them the potential to develop new cancer drugs that could be used clinically
    .

    Many metal-based therapies have been shown to be effective against cancer, with platinum-based drugs being the first-line chemotherapy drugs
    for testicular, bladder, lung, colon, and ovarian cancers.
    Some metal-based compounds, such as gold (III), hold promise as anti-cancer drugs but lack the stability
    needed to continue treatment development.
    Awuah's lab synthesized a new gold(III) that has a different structure and is more tolerant
    to therapeutic uses.

    In the lab, new chiral gold(III) compounds were studied on a group of cancer cell lines to test their effectiveness and understand how they attack cancer
    cells.

    These compounds show anticancer activity
    against aggressive triple-negative breast cancer cells.
    They also possess a new mechanism
    that leads to cellular mitochondrial dysfunction.

    Developing drugs that cause mitochondrial dysfunction deprives cancer cells of energy, a new and related strategy that can inhibit cancer growth, in combination with
    existing treatments, Awuah said.

    "Continued development of gold-based compounds has the potential to generate new drug mechanisms of action, and understanding how they alter cancer cells is important for drug design and has clinical implications
    ," Awuah said.

    Awuah is an assistant professor in the Department of Chemistry in the College of Arts and Sciences and holds a joint position
    in the Department of Pharmaceutical Sciences in the College of Pharmacy.
    His lab focuses on developing new methods to create chemical tools to interrogate complex biological processes as treatments for a variety of diseases, including cancer
    .


    Adedamola S.
    Arojojoye, Jong H.
    Kim, Chibuzor Olelewe, Sean Parkin, Samuel G.
    Awuah.
    Chiral gold(iii) complexes: speciation, in vitro, and in vivo anticancer profile.
    Chemical Communications, 2022; 58 (73): 10237

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.